Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nutripeutics takes antibiotic alternative work to KC

Oklahoma-based firm Nutripeutics is hoping to boost its product development by relocating to Kansas City. 

With the US FDA's mandate to remove antibiotics from livestock feed, Nutripeutics is one of many companies aiming to provide natural alternative solutions in this space.

The firm is aiming to develop its lead natural compound NutriBlend, which is designed to stimulate immune cells and produce host defence peptides. These peptides directly interact with the animal's bacterial cell membrane, punching a hole and releasing all of the bacteria's DNA and other genetic material, resulting in bacterial death.

According to Nutripeutics, this is a more effective method than antibiotics because NutriBlend does not actually affect the bacteria's environment. Instead, it increases production of the natural antibiotics and the likelihood of resistance is almost zero.

Nutripeutics claims: "This serves as a huge competitive advantage since resistance to antibiotics is one of the main reason why the FDA is mandating the removal of antibiotics from the feed of livestock animals."

Aside from NutriBlend, the firm is also exploring other potential antibiotic alternatives such as yeasts, carbohydrates, functional animal proteins, bacteriophages, acidifiers and probiotics.

On the move 

Currently, the firm's founder and chief executive Amanda Curtis is planning on moving from Oklahoma to Kansas City for the benefit of Nutripeutics.

Ms Curtis is exactly the sort of young entrepreneur the region is trying to attract into roles in the animal health industry. Recently, Kansas State University bolstered its goal of providing increased academic support for talent and workforce development by adding Paul Casady to its team.

Emily McVey, a director at the Kansas City Animal Health Corridor, recently told Animal Pharm: "With all the companies in the corridor, we have to make sure we are prepared to feed these assets. We have to engage young talent and make sure they realize the career opportunities in animal health."

"When you graduate most people want to become a vet or run their parent's practice," Ms Curtis told Animal Pharm at the recent Kansas City Animal Health Corridor Investment Forum. "No-one really thinks of industry. What I'm doing now, no-one would have really talked to me about it at university."

Ms Curtis earned a bachelor of animal science and a masters in animal molecular biology at Oklahoma State University. She also has a masters in business administration with an emphasis on entrepreneurship and a masters of management information technology from the University of Oklahoma. 

So with this scientific and business acumen, Ms Curtis established Nutripeutics to bring alternative antibiotics to the poultry sector.

Ms Curtis admitted to Animal Pharm it has been tough developing Nutripeutics. To fuel the firm's product development, she has been overseeing consultancy work under the Nutripeutics umbrella. These endeavors have seen her work with clients domestically and internationally to help with business development, technology or intellectual property.

Now, Ms Curtis is aiming to give Nutripeutics a major boost by bringing it to Kansas City. Here, she said the firm will be nearer angel investors and the many local animal health experts. 

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AP012971

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel